None of the single measles and mumps vaccines licensed in the United Kingdom is manufactured for, or marketed in the UK, and the licence holders advise that the products they manufacture outside the UK for other countries do not fully comply with their UK licences. None of the single measles and mumps vaccines imported into the UK are licensed for use in the UK, or in full compliance with an extant UK product licence. The United Kingdom is supplied by two manufacturers of measles, mumps and rubella vaccine and by one supplier of rubella vaccine. The cost to the Department of purchasing MMR and rubella vaccines is commercially confidential. Children are recommended to receive two doses of MMR vaccine.
Rubella vaccine is recommended for non- immune women.
This information is not available in the format requested. At 31 March 2000, the latest date for which figures are available, 87.6 per cent. 12.4 per cent. This means that approximately 75,000 children aged two at 31 March 2000 had not been immunised with the MMR vaccine by their 2nd birthday. 21.09 Major advertising spend on individual campaigns is shown in the table.